Style | Citing Format |
---|---|
MLA | Salari Z, et al.. "Sericin Alleviates Motor Dysfunction by Modulating Inflammation and Trkb/Bdnf Signaling Pathway in the Rotenone-Induced Parkinson’S Disease Model." BMC Pharmacology and Toxicology, vol. 24, no. 1, 2023, pp. -. |
APA | Salari Z, Ashabi G, Fartoosi A, Fartoosi A, Shariatpanahi M, Aghsami M, Montazeri H, Kheradmand A (2023). Sericin Alleviates Motor Dysfunction by Modulating Inflammation and Trkb/Bdnf Signaling Pathway in the Rotenone-Induced Parkinson’S Disease Model. BMC Pharmacology and Toxicology, 24(1), -. |
Chicago | Salari Z, Ashabi G, Fartoosi A, Fartoosi A, Shariatpanahi M, Aghsami M, Montazeri H, Kheradmand A. "Sericin Alleviates Motor Dysfunction by Modulating Inflammation and Trkb/Bdnf Signaling Pathway in the Rotenone-Induced Parkinson’S Disease Model." BMC Pharmacology and Toxicology 24, no. 1 (2023): -. |
Harvard | Salari Z et al. (2023) 'Sericin Alleviates Motor Dysfunction by Modulating Inflammation and Trkb/Bdnf Signaling Pathway in the Rotenone-Induced Parkinson’S Disease Model', BMC Pharmacology and Toxicology, 24(1), pp. -. |
Vancouver | Salari Z, Ashabi G, Fartoosi A, Fartoosi A, Shariatpanahi M, Aghsami M, et al.. Sericin Alleviates Motor Dysfunction by Modulating Inflammation and Trkb/Bdnf Signaling Pathway in the Rotenone-Induced Parkinson’S Disease Model. BMC Pharmacology and Toxicology. 2023;24(1):-. |
BibTex | @article{ author = {Salari Z and Ashabi G and Fartoosi A and Fartoosi A and Shariatpanahi M and Aghsami M and Montazeri H and Kheradmand A}, title = {Sericin Alleviates Motor Dysfunction by Modulating Inflammation and Trkb/Bdnf Signaling Pathway in the Rotenone-Induced Parkinson’S Disease Model}, journal = {BMC Pharmacology and Toxicology}, volume = {24}, number = {1}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Salari Z AU - Ashabi G AU - Fartoosi A AU - Fartoosi A AU - Shariatpanahi M AU - Aghsami M AU - Montazeri H AU - Kheradmand A TI - Sericin Alleviates Motor Dysfunction by Modulating Inflammation and Trkb/Bdnf Signaling Pathway in the Rotenone-Induced Parkinson’S Disease Model JO - BMC Pharmacology and Toxicology VL - 24 IS - 1 SP - EP - PY - 2023 ER - |